🌟 Honoring Rare Disease Day: Empowering Lives and Advocating for Hope 🌟 Our unwavering commitment at Helsinn is to stand alongside the 300 million individuals worldwide who grapple with rare diseases. These conditions, often shrouded in complexity, demand our collective attention and compassion. 🌱 Mycosis Fungoides-type Cutaneous T-cell Lymphoma (MF-CTCL), a rare form of cancer, exemplifies this challenge. Its gradual progression and elusive diagnostic journey underscore the critical need for awareness and support. 🔗 For deeper insights into MF-CTCL, explore the link below
Today marks Rare Disease Day, which aims to improve access to treatment and medical representation for the 300 million people worldwide with a rare disease. Helsinn is committed to supporting individuals living with Mycosis Fungoides-type Cutaneous T-cell Lymphoma (MF-CTCL), a rare cancer that progresses slowly and is often difficult to diagnose. For further details on MF-CTCL, follow the link: https://lnkd.in/gAj8TGX. To learn more about how you can support rare disease day, please visit: https://lnkd.in/gk6hbAF #RareDiseaseDay #RDD24